In vitro percutaneouus absorption of captopril

International Journal of Pharmaceutics

Volumn 148, Issue 1, 1997, Pages 41-46

  Wu, Pao Chu ^a   Huang, Yaw Bin ^a   Fang, Jia You ^a   Tsai, Yi Hung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aliphatic esters; Capropril; Concentration; Fatty alcohol; Human skin; N dodecyl lactame; Penetration enhancer; Penetration index; Pig skin

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ALCOHOL DERIVATIVE; BUTANOL; CAPTOPRIL; DECANOL; FATTY ALCOHOL; HEXANOL; LAURYL ALCOHOL; MACROGOL 400; MYRISTYL ALCOHOL; OCTANOL; PENETRATION ENHANCING AGENT; PROPYLENE GLYCOL; SORBITAN OLEATE; TOCOPHEROL; UNDECANOIC ACID; UREA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SKIN ABSORPTION; SKIN PERMEABILITY; SPECIES DIFFERENCE; SWINE;

EID: 0030896468     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04826-0     Document Type: Article

References (21)

1. Aungst, B., Rogers, N.J.J. and Shefter, E., Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amines. Int. J. Pharm., 33 (1986) 225-234.
2. Bronaugh, R.L. and Stewart, R.F., Method for in vitro percutaneous absorption studies. VI. Preparation of the barrier layer. J. Pharm. Sci., 75 (1986) 487-491.
3. Chien, Y.W., Novel Drug Delivery Systems. Marcel Dekker, New York, 1992.
4. Cooper, E.R., Merritt, E.W. and Smith R.L., Effect of fatty acid and alcohols on the penetration of acyclovir across human skin in vitro. J. Pharm. Sci., 74 (1985) 688-689.
5. Fang, J.Y., Wu, P.C. Huang, Y.B. and Tasi, Y.H., Percutaneous absorption of capsacin, nonivamide and sodium nonivamide acetate from gel and ointment bases: in vitro formulation evaluations in pigs and in vivo bioengineering method in humans. Int. J. Pharm., 130 (1996) 121-135.
6. Franz, N.J., Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol., 64 (1975) 190-195.
7. Goodman, M. and Barry, B.W., Action of penetration enhancers on human skin as assessed by the permeation of model drug 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol., 91 (1988) 323-327.
8. Goodman, M. and Barry, B.W., Lipid-protein-partitioning (LPP) theory of skin enhancer activity: finite dose technique. Int. J. Pharm., 57 (1989) 29-40.
9. Harada, K., Murakami, T., Kawasaki, E., Higashi, Y., Yamamoto, S. and Yata, N., In vitro permeability to salicylic acid of human, rodent and shed snake skin. J. Pharm. Pharmacol., 45 (1993) 414-418.
10. Jarrott, B., Drummer, O., Hooper, R., Anderson, A.I.E., Miach, P.J. and Louis, W.J., Pharmacokinetic properties of captopril after acute and chronic administration to hypertensive subjects. Am. J. Cardiol. 49 (1982) 1547.
11. Komata, Y., Inaoka, M., Kaneko, A. and Fujie, T., In vitro percutaneous absorption of thiamine disulfide from a mixture of propylene glycol and fatty acid. J. Pharm. Sci., 81 (1992a) 744-746.
12. Komata, Y., Kaneko, A. and Fujie, T., In vitro percutaneous absorption of thiamine disulfide through rat skin from a mixture of propylene glycol and fatty acid or its analog. Chem. Pharm. Bull., 40 (19925) 2173-2176.
13. Lambert, W.J., Higuchi, W.I., Kuntson, K. and Krill, S.L., Dose-dependent enhancement affects of azone on skin permeability. Pharm. Res., 6 (1989) 798-803.
14. Levy, M., Koren, G., Klein, J., McLorie, G. and Balfe, J.W., Captopril pharmacokinetics, blood pressure response and plasma renin activity in normotensive children with renal scarring. Dev. Pharmacol. Ther., 4 (1991) 185-193.
15. Raia, J.J., Toseph, J., Barone, J.A., Byerly, W.B. and Lacy, C.R., Angiotensin converting enzyme inhibitor: a comparative review. DICP Ann. Pharmacother., 24 (1990) 506-511.
16. Rigg, P.C. and Barry, B.W., Shed snake skin and hairless mouse skin as model menbranes for human skin during permeation studies. J. Invest. Dermatol., 94 (1990) 235-240.
17. Santoyo, S., Arellano, A., Ygartus, P. and Martin, C., Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. J. Pharm. Sci., 117 (1995) 219-224.
18. Trivedi, J.S., Krill, S.L. and Fort, J.J., Vitamin E as a human skin penetration enhancer. Eur. J. Pharm. Sci., 3 (1995) 241-243.
19. Wu, P.C., Fang, J.Y., Huang, Y.B. and Tsai, Y.H., In vitro effect of penetration enhancers on sodium nonivamide acetate in rat skin. Biol. Pharm. Bull., 18 (1995) 1790-1792.
20. Wu, P.C., Hung, Y.B., Lin, H.H. and Tsai, Y.H., In vitro percutaneous absorption of captopril through excised rabbit skin. Int. J. Pharm. 1996 (accepted for publication).
21. Zhou, X.H. and Li Wan Po, A., Stability and in vitro absorption of captopril, enalapril, and lisinopril across the rat intestine. Biochem Pharmacol., 47 (1994) 1121-1126.